Ibotta CEO Bryan Leach, trusts sell 49,899 shares
The Class B conversions were 1-for-1 and carried no cost, while all reported transactions were tied to a March 5, 2026 trading plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
On October 21, 2026, Ibotta, Inc. CEO and President Bryan Leach, a director and ten percent owner, exercised options for 21,407 Class A shares at an exercise price of $5.35 and 15,346 shares at $12.75. Transactions included sales of 49,899 Class A shares through direct holdings and the Elysian 2024 GST Trust and Orion 2024 GST Trust; each trust converted 6,573 Class B shares into Class A shares. These transactions were effected pursuant to a Rule 10b5-1 trading plan established March 5, 2026. As of October 21, 2026, reported holdings included 2,208,424 Class B shares directly and 289,500 Class B shares each in the Orion 2021 and Elysian 2021 Legacy Trusts, held by Leach's spouse as trustee.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) F1, F12 | 21,407 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (right to buy) F1, F12 | 15,346 | $0.00 | $0.00 |
| Conversion | Class B Common Stock F13, F1, F7 | 6,573 | $0.00 | $0.00 |
| Conversion | Class B Common Stock F13, F1, F9 | 6,573 | $0.00 | $0.00 |
| Exercise | Class A Common Stock F1, F2 | 21,407 | $5.35 | $115K |
| Exercise | Class A Common Stock F1, F2 | 15,346 | $12.75 | $196K |
| Sale | Class A Common Stock F1, F3, F2 | 6,911 | $48.4332 | $335K |
| Sale | Class A Common Stock F1, F4, F2 | 29,595 | $49.642 | $1.47M |
| Sale | Class A Common Stock F1, F5, F2 | 247 | $50.0415 | $12K |
| Conversion | Class A Common Stock F1, F6, F7 | 6,573 | $0.00 | $0.00 |
| Sale | Class A Common Stock F1, F3, F7 | 1,227 | $48.427 | $59K |
| Sale | Class A Common Stock F1, F4, F7 | 5,303 | $49.6415 | $263K |
| Sale | Class A Common Stock F1, F5, F7 | 43 | $50.0414 | $2K |
| Conversion | Class A Common Stock F1, F8, F9 | 6,573 | $0.00 | $0.00 |
| Sale | Class A Common Stock F1, F10, F9 | 1,299 | $48.4667 | $63K |
| Sale | Class A Common Stock F1, F11, F9 | 5,231 | $49.6484 | $260K |
| Sale | Class A Common Stock F1, F5, F9 | 43 | $50.0414 | $2K |
| holding | Class B Common Stock F13 | -- | -- | -- |
| holding | Class B Common Stock F13, F14 | -- | -- | -- |
| holding | Class B Common Stock F13, F15 | -- | -- | -- |
Footnotes (15)
- F1. The transactions reflected on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the Reporting Person on March 5, 2026.
- F2. Certain of these securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
- F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.95 to $48.91 per share. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.98 to $49.965 per share. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.04 to $50.045 per share. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F6. The Elysian 2024 GST Trust u/a/d/ March 20, 2024, converted 6,573 shares of Class B Common Stock into a like number of shares of Class A Common Stock.
- F7. By Spouse as Trustee for the Elysian 2024 GST Trust u/a/d March 20, 2024.
- F8. The Orion 2024 GST Trust u/a/d/ March 20, 2024, converted 6,573 shares of Class B Common Stock into a like number of shares of Class A Common Stock.
- F9. By Spouse as Trustee for the Orion 2024 GST Trust u/a/d March 20, 2024.
- F10. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $49.00 per share. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F11. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.01 to $49.965 per share. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F12. All of the shares subject to the option are fully vested and exercisable as of the date hereof.
- F13. Shares of Class B Common Stock are convertible into shares of Class A Common Stock on a 1-for-1 basis at no cost, at any time, at the election of the holder.
- F14. By Spouse as Trustee for the Orion 2021 Legacy Trust u/a/d May 11, 2021.
- F15. By Spouse as Trustee for the Elysian 2021 Legacy Trust u/a/d May 11, 2021.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
restricted stock units financial
fully vested and exercisable financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What option exercises did Bryan Leach report for IBTA?
AI-generated analysis. How Rhea-AI works. Not financial advice.